Recent reports indicate that the prognostic implications of left ventricular hypertrophy (LVH) are more profound in women than in men. The prognosis of LVH is also related to the underlying geometric pattern. We therefore assessed the relation of separate and concurrent influences of obesity and hypertension on genderspecific patterns of LV adaptation. Five hundred and twenty participants of a community-based study (aged 52 to 67 years) were examined by M-mode echocardiography. Study subjects were divided into four groups: normals, obese, hypertensives, and subjects presenting with both obesity and hypertension. The groups were compared for various measures of left ventricular mass (LVM) and geometry. Relative to normal subjects, the increments in wall thickness, ventricle diameters, and LVM were all significant and of similar magnitude for obese men and women. Likewise, hypertensive men and
Introduction
Left ventricular hypertrophy (LVH) is independently associated with substantial increases in the incidence of congestive heart failure and myocardial infarction as well as with cardiovascular and total mortality. [1] [2] [3] Obesity and hypertension, in themselves important independent predictors of cardiovascular morbidity and mortality, 4, 5 have also been identified as aetiologic factors in the development of LVH. [6] [7] [8] [9] Obesity and hypertension often coexist in the same patient 10, 11 and their joint influences on left ventricular mass (LVM) are reported to be at least additive. 9, 12 However, while eccentric hypertrophy is the predominant response pattern in obesity, concentric hypertrophy is more closely related to hypertension. [12] [13] In view of the recent notions that LVH confers a greater cardiovascular risk in women than men 14 and that cardiac adap-tations to obesity and hypertension are genderspecific, 12, 15, 16 the present study was undertaken in a community-based sample of middle-aged men and women to evaluate the influence of the separate and concurrent presence of obesity and hypertension on the left ventricle.
Subjects and methods

Study design and subjects
Data for this cross-sectional study were collected from February to June 1994 during a 10-year followup examination of the MONICA Augsburg cohort. Augsburg is the site of the international World Health Organisation Monitoring Trends and Determinants in Cardiovascular Disease (WHO-MONICA project), 17 located in the southern Federal Republic of Germany. During 1984 -1985, a cross-sectional survey was designed to measure the prevalence of cardiovascular risk factors in the 25-to 64-year-old population of Augsburg city and in the nearby rural areas of the counties of Augsburg and AichachFriedberg. 18 The participants in this baseline survey then formed the core for a cohort study and were invited to participate in a first follow-up examination in 1987-1988. This examination was attended by 3753 subjects (93.3%), with an age range of 28-67 years. From these subjects a subgroup of individuals aged 52 to 67 years was additionally invited for an echocardiographic examination, and 326 men and 368 women (overall participation 65.8%) were examined. Each participant was subjected to an interview comprising the individual's own and family medical history, lifestyle and a detailed recall of medications used over the last week, and a clinical and echocardiographic examination.
Measurements and definitions
Body height and weight were measured in light clothing. Body mass index (BMI) was computed as weight in kg divided by height in meters squared (kg/m 2 ). Obesity was defined according to National Institutes of Health Consensus Development Panel criteria 19 as a BMI greater than 27.8 kg/m 2 in men and 27.3 kg/m 2 in women. Resting blood pressure (BP) was measured after the subject had been in a sitting position for a minimum of 10 min, using a mercury sphygmomanometer. BP was read three times at the right arm. The mean of all three measurements was used for this study. According to WHO criteria (actual) hypertension was defined as BP у160 mm Hg systolic (SBP) or 95 mm Hg diastolic (DBP), or use of anti-hypertensive medication. 20 Using the 140/90 mm Hg cut-point for systolic and diastolic BP revealed fairly comparable results. However, to assess the effects of more severe and long-standing high BP which may be reflected by the use of anti-hypertensive medication, the former definition was used in the present analysis.
Two dimensional-guided M-mode echocardiograms were performed by two expert sonographers (MM, AL) trained in the same institution using the Sonos 1500 of Hewlett Packard Inc, USA. All Mmode tracings were recorded on stripchart paper at 50 mm/sec and were analysed by the senior observer (MM) who was blinded for all other data available for each subject. Only tracings with optimal visualisation of LV structures were allowed for this study, a restrictive requirement that resulted in the inclusion of 227 men and 293 women for further analyses. Subjects excluded from the analysis were slightly older (differences of 2 years, PϽ0.001) than those with adequate echocardiographic readings, however, there were no statistically significant differences in mean BMI, systolic or diastolic BP. Subjects with echocardiographic evidence of valvular heart disease (n = 2) were also excluded. LVM was determined according to the Penn convention 21 as:
based on measurements of LV end-diastolic diameter (LVD), septal wall thickness (SWT), and posterior wall thickness (PWT). Despite recent progress in two-dimensional echocardiographic determination of LVM, in the present study the M-mode technique was used because quantitative M-mode echocardiography remains widely used in the clinical as well as research setting. 22, 23 As suggested by Levy et al, 24 left ventricular mass (LVMI in g/m) as well as left ventricular end-diastolic diameter (LVDI in mm/m), septal wall thickness (SWTI in mm/m) and posterior wall thickness (PWTI in mm/m) were indexed to body height in the present study. LVH was assumed if LVMI was greater than 143 g/m in men and 102 g/m in women. 6, 24 A partition value of 0.41 for relative wall thickness (RWT) (based on Penn convention measurements) was obtained from an analysis of 465 healthy reference subjects of the MONICA-Augsburg population and represents the 97.5th percentile value. Based on RWT, defined as:
LV enlargement was considered as concentric hypertrophy if LVH was present and RWT Ͼ0.41, and eccentric hypertrophy if LVH was present with RWT р0.41.
Statistical analyses
To evaluate the differences in LV adaptation to the separate and joint influences of obesity and hypertension, we divided the study subjects into four subgroups: subjects being neither obese nor hypertensive (in the following indicated as 'normal'); subjects being obese but not hypertensive ('obese'); subjects with hypertension but without obesity ('hypertensive'); and subjects presenting with obesity plus hypertension ('obese-hypertensive'). Means and prevalences of baseline characteristics of the study subjects were calculated for men and women and their statistical significance was assessed by unpaired t-tests for continuous variables and by chisquare tests for prevalences. Analysis of covariance was applied to calculate age-adjusted mean values of LV parameters across the four groups of subjects. In order to assess gender differences (or effect modification by gender) and to account for the potential confounding effect of a higher rate of anti-hyperten- sive medication use in obese-hypertensive women, we tested the gender difference by use of an interaction term in a linear regression model encompassing the data of men and women while controlling for age and anti-hypertensive treatment.
Applying the method of 'marginal prediction' in the analysis of covariance models of logistic regression 25 age-adjusted prevalences of the geometric types of LVH were calculated for each of the subgroups. No major differences were observed between age-adjusted and crude prevalence estimates and we, therefore, present the latter only. All analyses were carried out for men and women separately with the SAS ® System for Windows Release 6.10.
Results
Characteristics of the study population (Table 1) Men and women were similar with regard to age, BMI, and SBP while DBP was slightly, though significantly, lower in females. While hypertension (BP у160/95 mm Hg or taking anti-hypertensive medication) alone was more common in men, obesity was more frequent in this group of largely postmenopausal women. The concurrence of obesity and hypertension was similarly frequent and encompassed approximately one-quarter of this study population. However, while the mean LVMI was significantly greater in men (128.5 vs 99.3 g/m, P Ͻ0.001), women had a considerably higher prevalence of LVH (38.2 vs 28.6%, P = 0.02).
Measurements of LV wall thickness, internal diameter, and mass (Tables 2 and 3)
Despite indexation to body height, normal women showed lower values than normal men in all echocardiographic variables with the exception of enddiastolic internal diameters which were almost identical for both genders.
Relative to normal subjects, age-adjusted mean values of LVM, posterior and septal wall thickness, and end-diastolic internal diameter were all significantly raised in obese men and women. Of note, there was no significant increase of RWT. Greater increases in absolute measures of LVMI for men (+25.7 vs +17.3 g/m) almost disappeared when expressed as increments relative to normal baseline levels (25.7/108.6 = +23.7% in men vs 17.3/81.6 = +21.2% in women).
Hypertensive men and women also displayed significantly greater LV masses, particularly in relative terms, than normals. However, while in both genders there was no difference to normals in the internal diameters, absolute wall thicknesses were even higher than in obese subjects and, in addition, the relative wall thicknesses were raised significantly in men and women (men 0.41 vs 0.35 in normals and women 0.39 vs 0.32, respectively, PϽ0.001 for each).
Obese-hypertensive women, but not men, had an increased LVM that was not only significantly greater than in normals but also than in obese or hypertensive women (122.1 vs 98.9 g/m and 101.8 g/m, respectively, P Ͻ0.001 for each). Likewise, their absolute and relative wall thicknesses were significantly elevated. The magnitude of the increase in age-adjusted LVM from normals to the group of obese-hypertensives was greater for women (+41g/m or +50%) compared to men (+33 g/m or +30%). In a regression model controlling for age and anti-hypertensive medication use, a significantly positive effect for female gender was confirmed (P Ͻ0.02). In addition, compared to normals the rise in RWT in that group of participants was significantly more pronounced in women than in men (P Ͻ0.02 for the interaction-term).
Prevalence and geometry of LVH
Despite a higher total prevalence of LVH in women, prevalences did not differ in normal men and women (Figure 1) . Concentric hypertrophy was predominant in normal men (prevalence 9%) and eccentric hypertrophy in normal women (13%). Hypertrophy was generally more common in obese, hypertensive and obese-hypertensive women taken together than in the respective men (52% vs 36%, P = 0.003).
Obese subjects showed most frequently the eccentric type of hypertrophy (Table 4) . By contrast, concentric hypertrophy was the dominating pattern in hypertensive men. The concurrent presence of obesity and hypertension in women resulted in further elevations of the prevalence of cardiac hypertrophy (+49% vs normals, +30% vs obese and +20.5% vs hypertensives, P Ͻ 0.05 for each). In contrast, raised LVH prevalences were observed for obese-hypertensive men only relative to normals (+26.5%, PϽ0.001) but not to obese or hypertensives. Obese-hypertensive women were specifically characterised by a high prevalence of concentric hypertrophy (44%) which clearly exceeded the prevalence of 31% in hypertensive women. We tested the gender-difference in the magnitude of the rise of concentric hypertrophy prevalence by use of a gender-interaction-term in a logistic regression model controlling for age and anti-hypertensive treatment. The analyses confirmed a significantly greater rise for obesehypertensive women, relative to normal subjects, than for men (P Ͻ0.03).
Applying other commonly used indexations, such as body height raised to the power of 2.0 or 2.7, or body surface area, revealed similar gender-specific relationships between LV geometry and concurrent hypertension and obesity. However, the increases in LVM with obesity were less marked for both genders than compared with indexations to body height. The results are not presented in detail.
Discussion
The present study on a community-based sample of middle-aged men and women revealed remarkable gender differences of LV geometry in response to hypertension and obesity. The results seem to indicate that the prevalence of LVH is generally higher in women. Furthermore, women respond more frequently with concentric hypertrophy to hypertension than men, a response that is particularly pronounced with concurrent obesity.
Separate influences of obesity and hypertension on LV adaptation
Consistent with numerous other reports, 13, [26] [27] [28] [29] obese subjects in our study presented predomi- nantly with eccentric and hypertensives with concentric patterns of LV adaptation. Few studies indicated that hypertension may also induce eccentric hypertrophy but such associations were observed mostly in the young. [30] [31] [32] A similar tendency in hypertensive men of our study (+8% for eccentric hypertrophy vs normals) missed statistical significance. We report here that adaptive myocardial changes in subjects with obesity were of very similar magnitude for both genders regardless of whether we looked at continuous parameters such as diastolic diameters or categorical variables such as the prevalence of eccentric hypertrophy. By contrast, hypertensive women showed much stronger increments of concentric hypertrophy than men while, clearly, there were no differences in the increase of LVM or RWT. In assessing this seemingly contradictory result one should probably consider the potential influence of an inappropriate selection of cut-points for the definition of LVH. 33, 34 We have recently pointed out that the partition values for LVH, as derived from the Framingham population, 6 may not be entirely appropriate for the Augsburg study sample and that they appear to overestimate the prevalence of LVH in women and, conversely, underestimate them in men. 35 Inappropriateness of cut-point selection could in part explain the result discrepancy between echocardiographic measurement means and prevalence of hypertrophy. On the other hand, pronounced increases of concentric hypertrophy are in accordance with other studies in older female hypertensives 15, 36 and may indicate a stronger responsiveness of the left ventricle to hypertension in women which becomes particularly prominent when obesity concurs.
Joint influences of obesity and hypertension on LV adaptation
We observed major gender differences in the geometric adaptations of the left ventricle to the concurrence of hypertension and obesity. These differences have only been marginally quantified in previous studies. 12, 26, 37 Most strikingly, obese-hypertensive women, but not men, from our study exhibited substantial increases in the prevalence of LVH. In particular, the concentric pattern of LVH was frequently observed in these subjects significantly exceeding the prevalences observed in normal, obese or hypertensive women. Of note, these were consistent for means of LVM, absolute and RWT as well as prevalence estimates, and they were confirmed by a significant formal statistical test for effect modification by gender. The higher proportion of anti-hypertensive medication use in obese-hypertensive women as compared to men in our study might be reason for concern. In fact, we found a strong positive association of anti-hypertensive medication use with LVM (+14.0 g/m, PϽ0.0001) controlling for age, BMI, sex, and BP, suggesting that use of anti-hypertensive medication reflects rather the adverse cardiac effects of a severe or long-standing hypertension than pharmacologically-induced LVM reductions. However, adjustment for anti-hypertensive medication use did not substantially alter the significant effect for obese-hypertensive women.
There is some evidence from both experimental 38, 39 as well as clinical studies 16 that oestrogen levels may exert a protective role on the development of LVH. The steeper increments of LVH prevalence in older women relative to men of the same age appear to support such an explanation. 40 More than 90% of the women in our study had passed the menopause. Thus, it may be hypothesised that postmenopausal reductions of circulating oestrogen levels render the female heart more susceptible to hypertrophic stimuli. Their concurrence, as in the case of the joint presence of obesity and hypertension, will then result in the effects observed in obese-hypertensive women in this study.
Several prospective studies have confirmed the prognostic significance of LVH for the occurrence of death and cardiac morbid events. 2, 3 The risk associated with concentric hypertrophy is particularly strong and largely independent of risk factor levels or pre-existing cardiac disease. [41] [42] [43] [44] [45] On the other hand, a recent report compared men and women, applying different indexations of LVM and varying partition values for the definition of LVH, to assess gender differences in the prognostic impact of the condition.
14 Irrespective of the definitions used, women presented with substantially higher relative risks for total and cardiac mortality compared with the male counterparts of this study. Consistent evidence for a greater risk of women with LVH can also be found in reports from the Framingham study. 2 Our results appear to indicate that such prognostic gender differences could be associated with the proneness of women to develop concentric LVH, a geometric pattern of left ventricle with most unfavourable prognosis.
44,45
Conclusion
We suggest that the hearts of postmenopausal women respond more susceptibly to the concurrence of trophic stimuli. In particular the prognostically less favourable concentric LVH is a common finding. Our study thus indicates potential explanations for the risk differences associated with LVH in men and women.
